# Jefferies Financial Group

Type: Company (JEF)

Source: Finance Intelligence Brief — https://getfinancebrief.com/entity/jefferies-financial-group
Canonical HTML page: https://getfinancebrief.com/entity/jefferies-financial-group

## Timeline

- **2026-07-08**: Wells Fargo Cuts Target to $70 — Wells Fargo & Company lowers Freshpet’s price target from $75.00 to $70.00, keeping an Overweight rating, implying 28.42% upside.
- **2026-07-01**: Bank of America Lowers Target — Bank of America reduces its price target from $75.00 to $70.00 and maintains a Neutral rating.
- **2026-06-15**: Piper Sandler Stays Overweight — Piper Sandler reaffirms an Overweight rating on Freshpet shares.
- **2026-06-01**: Weiss Ratings Downgrades — Weiss Ratings cuts Freshpet from 'Hold (c)' to 'Hold (c-)'.
- **2026-05-07**: JPMorgan Upgrades, Others Reaffirm — JPMorgan raises rating from Neutral to Overweight and lifts target from $66.00 to $68.00. Morgan Stanley reiterates Overweight with $77.00 target, while Deutsche Bank holds at Hold with $63.00 target.
- **2026-04-22**: Jefferies Cuts Target — Jefferies Financial Group lowers its price objective from $75.00 to $70.00 and maintains a Hold rating.
- **2026-04-08**: TD Cowen Turns Bullish — TD Cowen upgrades Freshpet from Hold to Buy and sets an $80.00 price objective.
- **2026-03-20**: Oppenheimer Upgrades Freshpet — Oppenheimer raises Freshpet from Market Perform to Outperform with an $80.00 price target.

## Recent coverage (6 stories)

### Wabtec FY26 EPS $10.60-$10.90, Moody's $16.50-$17.00: Both Miss Consensus
2026-07-23 02:24:25 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wabtec guided revenue between $12.3-$12.6B and EPS slightly below the Street, while Moody’s EPS range also came in under estimates. Analysts remain constructive with moderate buy ratings and double-digit upside targets for both stocks.
Full story: https://getfinancebrief.com/story/wabtec-moodys-fy26-guidance-analysis

### MCRI Beats Q2 EPS by $0.11; $2.21B Casino Stock Eyes $144 Target Amid Insider Sale
2026-07-21 01:35:47 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Monarch Casino & Resort posted a second-quarter earnings beat of $0.11 per share on revenue strength, driving the stock up 1.1% to $124.38. Valuation metrics remain solid with a P/E of 21.08 and a 1% dividend yield, but a recent CEO stock sale and mixed analyst ratings signal a cautious bias. Truist’s $144 price target offers the most bullish outlook, while Stifel sits at $102.
Full story: https://getfinancebrief.com/story/mcri-earnings-beat-011-eps-analyst-targets-insider-sale

### Wells Fargo Cuts Freshpet Target to $70, Still Sees 28% Upside
2026-07-09 13:12:08 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wells Fargo lowered its price target on Freshpet to $70 from $75 while maintaining an Overweight rating, implying the stock is undervalued by 28%. The market remains skeptical with FRPT trading at $54.51, well below the consensus analyst target of $74.25. Analysts overall rate the pet food company a Moderate Buy, despite a string of recent target cuts.
Full story: https://getfinancebrief.com/story/wells-fargo-cuts-freshpet-target-70-upside

### 36bp of rate hikes by end-2026? AI spending blamed for sticky inflation
2026-06-21 10:53:10 · Sentiment: Neutral · Impact: 7/10 · Sources: 2

A new Jefferies report warns that the massive AI infrastructure buildout is keeping U.S. inflation elevated, forcing markets to price in further rate hikes. Two-year Treasury yields just saw their biggest one-day jump in 14 months, and money markets now expect 36 basis points of tightening by year-end.
Full story: https://getfinancebrief.com/story/ai-spending-inflation-fed-rate-hikes

### Zacks Issues Strong Sell Ratings for Fortescue and Kering Amid China Headwinds
2026-03-22 01:05:00 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Zacks Research has issued rare 'Strong Sell' ratings for both Australian mining giant Fortescue and French luxury conglomerate Kering. The downgrades highlight deepening concerns over earnings estimate revisions and the companies' heavy exposure to a cooling Chinese economy.
Full story: https://getfinancebrief.com/story/zacks-downgrades-fortescue-kering-strong-sell

### AxoGen Surges as Wells Fargo Issues Rare 'Strong-Buy' Rating Upgrade
2026-02-21 01:12:47 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

AxoGen (NASDAQ: AXGN) has received a major boost from Wall Street as Wells Fargo upgraded the nerve-repair specialist to a 'Strong-Buy' rating. The upgrade follows a significant price target hike from Jefferies, signaling a robust consensus on the company's growth potential in the medical technology sector.
Full story: https://getfinancebrief.com/story/axogen-axgn-wells-fargo-strong-buy-upgrade

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getfinancebrief.com/guides/methodology for the full editorial methodology.